Aliskiren

Aliskiren (brand names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.[1] While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit.[2] In December 2011, Novartis halted a trial of the drug after discovering increased nonfatal stroke, kidney complications, high blood pota... [wikipedia]